CSPC Pharmaceutical Group Limited (HKG:1093)
8.59
-0.06 (-0.69%)
At close: Mar 13, 2026
CSPC Pharmaceutical Group Revenue
CSPC Pharmaceutical Group had revenue of 6.62B CNY in the quarter ending September 30, 2025, with 3.37% growth. This brings the company's revenue in the last twelve months to 26.21B, down -13.40% year-over-year. In the year 2024, CSPC Pharmaceutical Group had annual revenue of 29.01B, down -7.76%.
Revenue (ttm)
26.21B CNY
Revenue Growth
-13.40%
P/S Ratio
3.43
Revenue / Employee
1.36M CNY
Employees
19,266
Market Cap
98.21B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 29.01B | -2.44B | -7.76% |
| Dec 31, 2023 | 31.45B | 513.21M | 1.66% |
| Dec 31, 2022 | 30.94B | 3.07B | 11.02% |
| Dec 31, 2021 | 27.87B | 2.92B | 11.73% |
| Dec 31, 2020 | 24.94B | 2.84B | 12.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 626.85B |
| JD Health International | 81.73B |
| BeOne Medicines AG | 41.59B |
| Alibaba Health Information Technology | 36.09B |
| Sino Biopharmaceutical | 33.49B |
| WuXi Biologics | 21.98B |
| Hansoh Pharmaceutical Group Company | 14.45B |
| Innovent Biologics | 12.52B |
CSPC Pharmaceutical Group News
- 6 weeks ago - AstraZeneca Strikes Multibillion-Dollar Obesity Deal With China's CSPC - WSJ
- 6 weeks ago - China's CSPC Pharmaceutical inks deal with AstraZeneca for weight loss therapy - Reuters